1i3k: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1i3k.jpg|left|200px]]
{{Seed}}
[[Image:1i3k.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1i3k|  PDB=1i3k  |  SCENE=  }}  
{{STRUCTURE_1i3k|  PDB=1i3k  |  SCENE=  }}  


'''MOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M-SUBSTITUTED UDP-GALACTOSE 4-EPIMERASE'''
===MOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M-SUBSTITUTED UDP-GALACTOSE 4-EPIMERASE===




==Overview==
<!--
Galactosemia is an inherited disorder characterized by an inability to metabolize galactose. Although classical galactosemia results from impairment of the second enzyme of the Leloir pathway, namely galactose-1-phosphate uridylyltransferase, alternate forms of the disorder can occur due to either galactokinase or UDP-galactose 4-epimerase deficiencies. One of the more severe cases of epimerase deficiency galactosemia arises from an amino acid substitution at position 94. It has been previously demonstrated that the V94M protein is impaired relative to the wild-type enzyme predominantly at the level of V(max) rather than K(m). To address the molecular consequences the mutation imparts on the three-dimensional architecture of the enzyme, we have solved the structures of the V94M-substituted human epimerase complexed with NADH and UDP-glucose, UDP-galactose, UDP-GlcNAc, or UDP-GalNAc. In the wild-type enzyme, the hydrophobic side chain of Val(94) packs near the aromatic group of the catalytic Tyr(157) and serves as a molecular "fence" to limit the rotation of the glycosyl portions of the UDP-sugar substrates within the active site. The net effect of the V94M substitution is an opening up of the Ala(93) to Glu(96) surface loop, which allows free rotation of the sugars into nonproductive binding modes.
The line below this paragraph, {{ABSTRACT_PUBMED_11279193}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 11279193 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_11279193}}


==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: Wohlers, T M.]]
[[Category: Wohlers, T M.]]
[[Category: Galactosemia epimerase short-chain dehydrogenase]]
[[Category: Galactosemia epimerase short-chain dehydrogenase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 19:31:52 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 10:21:38 2008''

Revision as of 10:21, 1 July 2008

File:1i3k.png

Template:STRUCTURE 1i3k

MOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M-SUBSTITUTED UDP-GALACTOSE 4-EPIMERASEMOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M-SUBSTITUTED UDP-GALACTOSE 4-EPIMERASE

Template:ABSTRACT PUBMED 11279193

About this StructureAbout this Structure

1I3K is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase., Thoden JB, Wohlers TM, Fridovich-Keil JL, Holden HM, J Biol Chem. 2001 Jun 8;276(23):20617-23. Epub 2001 Mar 7. PMID:11279193

Page seeded by OCA on Tue Jul 1 10:21:38 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA